Molecular Testing for Bethesda III Thyroid nodules: Trends in Implementation, Cytopathology Call Rates, Surgery Rates, and Malignancy Yield at a Single Institution

恶性肿瘤 医学 置信区间 不确定 细针穿刺 产量(工程) 细胞病理学 细胞学 内科学 病理 活检 数学 冶金 材料科学 纯数学
作者
Mason Stillman,Eric J. Kuo,Rachel Liou,Abdullah Almuqate,Renu K. Virk,James A. Lee,Jennifer H. Kuo,Catherine McManus
出处
期刊:Thyroid [Mary Ann Liebert, Inc.]
卷期号:34 (4): 460-466 被引量:4
标识
DOI:10.1089/thy.2023.0664
摘要

Background: Molecular testing (MT) has become standard practice to more accurately rule out malignancy in indeterminate Bethesda III (BIII) thyroid lesions. We sought to assess the adoption of this technology and its impact on cytology reporting, malignancy yield, and rates of surgery across community and academic sites affiliated with a tertiary medical center. Methods: We performed a retrospective cross-sectional study including all fine-needle aspirations (FNAs) analyzed at our institution from 2017 to 2021. We analyzed trends in MT utilization by platform and by community or academic site. We compared BIII call rates, MT utilization rates, rates of subsequent surgery, and malignancy yield on final pathology before and after MT became readily available using chi-square analysis and linear regression. Results: A total of 8960 FNAs were analyzed at our institution from 2017 to 2021. There was broad adoption of MT across both community and academic sites. There was a significant increase in both the BIII rate and the utilization of MT between the pre- and post-MT periods (p < 0.001 and p < 0.001). There was no significant change in the the malignancy yield on final pathology (57.1% vs. 50.0%, p = 0.347), while the positive predictive value of MT decreased from 85% to 50% (p = 0.008 [confidence interval 9.5-52.5% decrease]). Conclusions: The use of MT increased across the institution over the study period, with the largest increase seen after a dedicated pass for MT was routinely collected. This increased availability of MT may have led to an unintended increase in the rates of BIII lesions, MT utilization, and surgery for benign nodules. Physicians who use MT should be aware of potential consequences of its adoption to appropriately counsel patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
方源的应助被YanYi采纳,获得20
刚刚
wy发布了新的文献求助10
3秒前
3秒前
义气铅笔完成签到 ,获得积分20
3秒前
3秒前
杨总完成签到,获得积分10
4秒前
Lucas的应助被灵巧绿海采纳,获得10
5秒前
JamesPei的应助被zero采纳,获得10
5秒前
黑眼圈完成签到 ,获得积分0
6秒前
爱学习的陈默默关注了科研通微信公众号
6秒前
大个的应助被学做科研采纳,获得10
7秒前
NYding完成签到,获得积分10
9秒前
暴躁的奇异果完成签到,获得积分10
9秒前
研友_LN3BMn完成签到,获得积分10
11秒前
科研通AI6.4的应助被灵巧绿海采纳,获得10
11秒前
12秒前
星辰大海的应助被大鸟文采纳,获得10
12秒前
12秒前
火星上的西牛完成签到,获得积分10
13秒前
zyg完成签到,获得积分10
13秒前
14秒前
bawanglong完成签到,获得积分10
14秒前
大模型的应助被哦哦啊啊啊采纳,获得10
14秒前
齐天小圣完成签到 ,获得积分10
15秒前
李健的小迷弟的应助被giA采纳,获得10
16秒前
土豪的洋葱完成签到,获得积分10
16秒前
18秒前
行走发布了新的文献求助10
19秒前
尊敬的雨竹完成签到,获得积分20
19秒前
sure完成签到 ,获得积分10
19秒前
Max完成签到,获得积分10
19秒前
可研完成签到 ,获得积分10
20秒前
义气铅笔关注了科研通微信公众号
20秒前
严xixi完成签到 ,获得积分10
20秒前
20秒前
21秒前
21秒前
unyield完成签到,获得积分10
22秒前
23秒前
大鸟文完成签到,获得积分10
23秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190698
求助须知:如何正确求助?哪些是违规求助? 9577768
关于积分的说明 21854810
捐赠科研通 7789827
什么是DOI,文献DOI怎么找? 3436452
关于科研通互助平台的介绍 2560302
邀请新用户注册赠送积分活动 2483169